Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.80
Bid: 36.60
Ask: 37.30
Change: 2.80 (8.24%)
Spread: 0.70 (1.913%)
Open: 35.00
High: 37.30
Low: 35.00
Prev. Close: 34.00
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Change At Top For Well-Performing Hargreaves Lansdown

Wed, 07th Sep 2016 07:25

LONDON (Alliance News) - Hargreaves Lansdown, the FTSE 100-listed fund supermarket, said Chief Executive Ian Gorham will step down next year after seven years in the role, replaced by Chief Financial Officer Chris Hill, who joined Hargreaves in March from IG Group.

The announcement came as Hargreaves reported growth in profit, net revenue and assets under administration in its financial year to the end of June. The stock was off 1.5% in a narrowly mixed early market.

Providing some early excitement among small-cap stocks, Futura Medical shares jumped 55% out of the blocks after reporting positive test results for its erectile dysfunction gel.

Significant, but likely to be considerably less exciting, Bank of England Governor Mark Carney testifies before the Treasury Select Committee of Parliament starting at 1000 GMT.

Here is what you need to know at the London market open:
----------
MARKETS
----------
FTSE 100: flat at 6,827.47
FTSE 250: down 0.1% at 17,994.33
AIM ALL-SHARE: up 0.1% at 798.85
----------
Hang Seng: down 0.2% at 23,737.14
Nikkei 225: closed down 0.4% at 17,012.44
DJIA: closed up 0.3% at 18,538.12
S&P 500: closed up 0.3% at 2,186.48
----------
GBP: flat at USD1.3414 (USD1.3424)
EUR: firm at USD1.1250 (USD1.1227)

GOLD: up at USD1,350.82 per ounce (USD1,339.59)
OIL (Brent): up at USD47.49 a barrel (USD46.81)

(changes since previous London equities close)
----------
ECONOMICS AND GENERAL
----------
Wednesday's Key Economic Events still to come
(all times in BST)

0830 UK Halifax house prices
0930 UK industrial and manufacturing production
1000 UK Inflation Report hearings
1015 UK BoE MPC Member Cunliffe speech
1200 US MBA mortgage applications
1355 US Redbook index
1500 US JOLTS job openings
1500 UK NIESR GDP estimate
1500 Canada BoC interest rate decision and statement
1500 Canada Ivey purchasing managers index
1900 US Fed's Beige Book
2130 US API Weekly crude oil stocks
----------
UK Prime Minister Theresa May will face a grilling from MPs Wednesday amid concerns that the government is struggling to agree a strategy for Brexit. The Prime Minister has distanced herself from Brexit Secretary David Davis's suggestion that it is "very improbable" the UK can regain control over its own borders while remaining part of the European single market. The apparent rebuke sparked concerns that ministers are "confused" and cannot agree policy on leaving the European Union, and May is expected to face questions on the issue after delivering a Commons statement on the G20 summit in China.
----------
UK Chancellor of the Exchequer Philip Hammond will on Wednesday meet City grandees to discuss how to use his first mini-Budget to boost the economy amid the backdrop of Brexit. Ahead of the Autumn Statement, Hammond will meet several members of the European Financial Services Chairmen's Advisory Committee, including chairman and Santander UK boss Baroness Vadera. The committee was set up to analyse how Britain's financial services sector can deal with the economic fallout of the shock vote to leave the European Union.
----------
Germany's industrial production declined unexpectedly in July, data from Destatis showed. Industrial output declined 1.5% month-on-month in July, confounding expectations for an increase of 0.1%. Production had increased 1.1% in June, which was revised up from 0.8%.
----------
Japan's leading index dropped in July after recovering last month, survey results from the Cabinet Office revealed. The leading index, which measures the future economic activity, fell to 100 in July from revised 100.7 in June. The expected reading was 98.6.
----------
The Association of South-East Asian Nations and China were expected Wednesday to adopt a protocol aimed at preventing clashes resulting from unplanned encounters in the disputed South China Sea. The signing of the Code for Unplanned Encounters at Sea at a summit in Vientiane, Laos comes as the Philippines warned China might be preparing for fresh construction work. Officials said the agreement on communications protocols would be "very important" in preventing potential clashes.
----------
The US presidential candidates traded personal attacks as they provided more access to reporters trying to keep up with the quickening pace of the campaign. Republican Donald Trump, in another provocative comment about a woman's appearance, said Democratic candidate Hillary Clinton lacks "a presidential look," while she criticized him for not releasing his tax returns, saying he "clearly has something to hide." "I just don't think she has a presidential look, and you need a presidential look," Trump told ABC News.
----------
BROKER RATING CHANGES
----------
GOLDMAN INITIATES SSE WITH 'NEUTRAL' - TARGET 1603 PENCE
----------
GOLDMAN CUTS CENTRICA TO 'SELL' ('NEUTRAL') - TARGET 213 (211) PENCE
----------
TRADERS: MERRILL LYNCH CUTS UNITED UTILITIES TO 'UNDERPERFORM'
----------
TRADERS: MERRILL LYNCH CUTS SEVERN TRENT TO 'UNDERPERFORM'
----------
DEUTSCHE BANK CUTS EASYJET TO 'HOLD' ('BUY') - TARGET 1,215 (1,310) PENCE
----------
UBS RAISES AVIVA TO 'BUY' ('NEUTRAL') - TARGET 505 (395) PENCE
----------
TRADERS: EXANE BNP CUTS RECKITT BENCKISER TO 'NEUTRAL' (OUTPERFORM)
----------
COMPANIES - FTSE 100
----------
Fund supermarket Hargreaves Lansdown said its chief executive will step down by the end of September 2017, as it reported growth in profit, net revenue and assets under administration in its financial year to the end of June. Hargreaves said Ian Gorham will step down as CEO, having served seven years in the role, by the end of September 2017. Chris Hill, currently chief financial officer, will become deputy chief executive of the company from October 1 this year and will take over from Gorham when the incumbent CEO leaves. Hill joined Hargreaves in March from online trading firm IG Group Holdings. The news of the CEO succession plan came as Hargreaves said pretax profit for the year to June 30 grew 10% year-on-year to GBP218.9 million from GBP199.0 million a year prior. The group will pay a second interim dividend of 16.30 pence per share, taking its total payout for the year to 34.00p, up 3.0%.
----------
Barratt Developments said its sales trend since the end of June had been encouraging and underpinned a "business-as-usual" stance following the Brexit decision, as the UK housebuilder reported a 21% rise in pretax profit for its financial year. Barratt reported 267 average weekly net private reservations since July 1, up from 265 in the same period of 2015, resulting in net private reservations per active outlet per average week of 0.75, up from 0.71 the prior year. The comments came as Barratt reported a 13% rise in revenue for its year ended June 30 to GBP4.24 billion from GBP3.76 billion the prior year, after it sold more homes at higher prices. This drove a 21% increase in pretax profit to GBP682.3 million from GBP565.5 million, and Barratt hiked its final dividend to 12.30 pence per share up from 10.3p per share. This, together with a 12.40p per share special dividend and the interim dividend, meant the full-year dividend offered was 30.70p per share, up from 25.10p per share the prior year.
----------
Private equity firms Advent International and Bain Capital sold a larger-than-planned stake in payments company Worldpay Group through their Ship Global 2 vehicle, Bank of America Merrill Lynch confirmed. The investment bank said the pair had sold 350.0 million shares through the Ship Global 2 vehicle at 282.00p per share, giving the transaction as total value of GBP987.0 million. Shares in Worldpay closed at 294.40p on Tuesday. Following completion of the placing, Ship Global 2 will have a stake of around 11% in Worldpay.
----------
Equipment rental company Ashtead Group said the weakness of sterling following the UK's EU membership vote will mean its full-year results are likely outpace its current expectations, as it said first quarter profit and revenue grew. Ashtead said pretax profit for the quarter to the end of July grew to GBP177.9 million, from GBP155.4 million a year earlier, while revenue increased to GBP707.1 million from GBP618.6 million. Underlying rental revenue for Ashtead grew 12% in constant currencies, with strong growth from its Sunbelt business in the US and from its A-Plant arm in the UK.
----------
COMPANIES - FTSE 250
----------
Sports Direct International said Chairman Keith Hellawell has been asked by the board, and by Founder and Deputy Executive Chairman Mike Ashley, to continue his role at the company. The sporting goods retailer said Hellawell had offered to step down last weekend "in light of the shortcomings" highlighted in the company's working practices report. Separately, Sports Direct, which holds its AGM Wednesday said it expects underlying earnings before interest, tax, depreciation and amortisation for its full financial year to be in the region of GBP300 million, subject to sales growth of at least 9% year-on-year, a gross margin decline of no worse than 275 basis points, and an increase in operating costs of no more than 8%.
----------
Vectura Group raised its revenue expectations for the nine months to end December 31, thanks to its current strong trading performance. The company, which primarily focuses on treatments for inhaled airways disease, said the combined recurring royalty and product supply revenue from marketed inhaled products are ahead of previous expectations for 2016.
----------
Online retail trading firm CMC Markets said it has continued to make progress in its current financial year so far but said a lack of volatility in markets will hit its net operating income in the first half. In the five months to the end of August, CMC said new client numbers have increased 19% year-on-year, while active clients are up 9.0%. However, CMC said lower levels of volatility have constrained trading opportunities for clients and, as a result, the value of client trades is lower year-on-year and the group said net operating income for the half to the end of September is anticipated to decline.
----------
BGEO Group said it has appointed Kakhaber Kiknavelidze as the new chief executive of its Bank of Georgia arm. He will take over from Murtaz Kikoria, who will leave BGEO in order to pursue a career outside the banking sector. Kiknavelidze will report to Irakli Gilauri, BGEO's group CEO.
----------
Defence contractor Ultra Electronics Holdings said it has secured a GBP7.5 million contract to restore and sustain two Jacinto Class patrol vessels in the Philippines. The contract, awarded by the Philippine Department of National Defence, will include the replacement of the electro-optic fire control system and navigation sensors on the vessels, plus the overhaul of the 25mm and 76mm guns on the ships.
----------
COMPANIES - LONDON MAIN MARKET AND AIM
----------
Futura Medical said its MED2002 erectile dysfunction gel achieved its primary endpoint in its recent efficacy study. Futura said MED2002 successfully demonstrated efficacy, safety and speed of onset in the study and showed a statistically significant improvement in treating erectile dysfunction compared to a placebo. Futura shares rocketed at the open on Wednesday, up 58% to 45.00 pence.
----------
Software firm Servelec Group said it is trading in line with its revised expectations as it reported a sharp decline in profit for the first half of 2016. Servelec warned in June that operating profit in 2016 would be lower than its previous expectations due to contract delays hitting some of its divisions. On Wednesday, it said those issues had meant pretax profit fell 65% in the first half to GBP1.7 million from GBP4.8 million a year prior. Revenue slipped to GBP28.4 million from GBP30.0 million and order intake for the company sunk 15% to GBP37.4 million from GBP44.1 million a year before. Servelec declared a flat interim dividend of 1.65 pence.
----------
Consort Medical said it continues to trade in line with the board's expectations for its current financial year, on a constant currency basis, as it announced a new contract with pharmaceutical giant AstraZeneca. The drug delivery device company said its new contract with AstraZeneca is for the supply of its Bespak respiratory devices.
----------
COMPANIES - INTERNATIONAL
----------
Volkswagen is in advanced talks with China's Anhui Jianghuai Automobile Co about jointly producing electric passenger vehicles in the country, Bloomberg reported citing people familiar with the matter. An announcement could come as early as Wednesday, the report said. Jianghuai Auto plans to sign a memorandum of cooperation that will have major impact, the Hefei, China-based company said late Tuesday, without identifying the partner.
----------
Airbus Group said it delivered a total of 61 jetliners in August. Airbus said the planes shipped, including six A350 long-range jets, were an August record. Deliveries in August brought to 400 the total number of jetliners provided by Airbus to 70 customers during the first eight months of 2016.
----------
Dell Technologies announced its fiscal 2017 second quarter results, with revenue of USD13.1 billion from continuing operations, an increase of 1% year-over-year. Non-GAAP revenue in the quarter was USD13.1 billion, flat from the previous year. Last month, Dell Inc and EMC Corp announced they intended to close the transaction to combine Dell and EMC on Wednesday. Dell Technologies, the name of the new combined company, would begin operating immediately following the close of the transaction.
----------
Starbucks Corp, the world's largest coffee retailer, will start serving calorie-free stevia sweetener in the US and Canada and has has started testing a weekend-only brunch menu in 78 locations in Portland and Seattle. Stevia is a sweetener and sugar substitute extracted from the leaves of the plant. Starbucks will serve Whole Earth Sweetener Company's Nature Sweet packets at all of its outlets in the US and Canada.
----------
Wednesday's Shareholder Meetings

Ashtead Group
Sports Direct International
Poundland Group (re recommended cash offer by Steinhoff Europe)
Consort Medical
Trakm8 Holdings
Zoltav Resources
Stewart & Wight
Marlowe
Carpetright
CMC Markets
Matchtech Group (re name change to Gattaca)
AEW UK REIT
Vectura Group
----------
By Tom Waite; thomaslwaite@alliancenews.com; @thomaslwaite

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
9 Aug 2023 12:07

IN BRIEF: Futura Medical's ED treatment approved in Saudi Arabia

Futura Medical PLC - Surrey, England-based pharmaceutical company - Says its distribution partner, Labatec Pharma, received regulatory approval for MED3000 in Saudi Arabia. MED3000 is Futura's topical, gel-based erectile dysfunction treatment. Labatec will exclusively launch and commercialise MED3000 under the brand name Eroxon, with initial launch planned in the final quarter of 2023. Adds the manufacturing of Eroxon for launch has been completed.

Read more
18 Jul 2023 14:16

Futura Medical chair steps down, promotes non-executive director

(Alliance News) - Futura Medical PLC on Tuesday said it appointed Non-Executive Chair Jeff Needham as the successor to outgoing chair John Clarke, who has stepped down.

Read more
17 Jul 2023 09:13

Futura Medical agrees US licensing deal with Haleon for Med3000 gel

(Alliance News) - Futura Medical PLC on Monday said it agreed a licensing deal with Haleon PLC for the rights to exclusively commercialise Futura's erectile dysfunction treatment Med3000 in the US.

Read more
17 Jul 2023 08:33

Futura Medical shares rise on ED licensing deal with Haleon

(Sharecast News) - Shares in Futura Medical gained on Monday after the company said it signed a licensing deal with consumer heath care giant Haleon for the rights to exclusively commercialise its topical, gel-based erectile dysfunction treatment MED3000 in the USA.

Read more
22 Jun 2023 14:45

IN BRIEF: Futura Medical hails continued momentum after Eroxon launch

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says it is encouraged by the early growth trajectory of erectile dysfunction treatment gel Eroxon following its recent launch. "Both initial orders of Eroxon by our partners and in-market demand have been in line with our expectations and should continue to build as partners expand sales channels, numbers of outlets and new geographies," it adds. Predicts that net revenue for the six months ending June 30 will be no less than GBP1.5 million. Says momentum continues to build as it enters the commercialisation phase and positions itself to receive its first significant revenue in 2023. It previously in April said that its 2022 pretax loss widened to GBP6.9 million from GBP5.8 million the year before.

Read more
15 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Friday 16 June 
Alpha Growth PLCAGM
Anglo-Eastern Plantations PLCAGM
Gulf Keystone Petroleum LtdAGM
John Lewis of Hungerford PLCGM re proposed cancellation of admission to trading on AIM
Tesco PLCAGM
Woodbois LtdAGM
Monday 19 June 
All ThingsConsidered Group PLCAGM
Blackbird PLCAGM
Finsbury Food Group PLCAGM
Globalworth Real Estate Investments LtdAGM
Marlowe PLCGM re proposed capital reduction
Metals Exploration PLCAGM
Red Rock Resources PLCGM re security conversion into shares for cash
Savannah Resources PLCAGM
Tuesday 20 June 
Acceler8 Ventures PLCAGM
Afentra PLCAGM
Armadale Capital PLCAGM
Bay Capital PLCAGM
Blackrock Smaller Companies Trust PLCAGM
Block Energy PLCAGM
Corero Network Security PLCAGM
Coro Energy PLCAGM
Crimson Tide PLCAGM
Curtis Banks Group PLCAGM
EPE Special Opportunities LtdAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Jersey Oil & Gas PLCAGM
Kore Potash PLCAGM
Lords Group Trading PLCAGM
Mission Group PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Red Capital PLCAGM
Saga PLCAGM
SDX Energy PLCAGM
Skillcast Group PLCAGM
Zegona Communications PLCAGM
Wednesday 21 June 
Argentex Group PLCAGM
Clean Power Hydrogen PLCAGM
Eqtec PLCAGM
Hydrogen Utopia International PLCAGM
HSS Hire Group PLCAGM
Intelligent Ultrasound Group PLCAGM
JD.com IncAGM
RTW Venture Fund LtdAGM
Schroders Capital Global Innovation Trust PLCAGM
Sivota PLCAGM
Numis Corp PLCGM re acquisition by Deuche Bank AG
THG PLCAGM
UK Commercial Property REIT LtdAGM
Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM

 

Read more
12 Jun 2023 12:08

LONDON MARKET MIDDAY: Stocks firm as expected Fed pause still in doubt

(Alliance News) - Stock prices in London were tentatively higher at midday on Monday, as investors looked ahead to a key US inflation print on Tuesday with some caution ahead of the Federal Reserve's next interest rate decision.

Read more
12 Jun 2023 10:13

AIM WINNERS & LOSERS: Ovoca Bio drops as Orenetide study delayed

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
12 Jun 2023 09:47

Futura shares jump after FDA approval for erectile dysfunction product

(Alliance News) - Futura Medical PLC said on Monday that the US Food & Drug Administration granted over the counter sale marketing authorising for MED3000, the company's treatment of erectile dysfunction.

Read more
18 Apr 2023 13:09

Futura's erection gel launched over-the-counter in the UK

(Sharecast News) - Sexual health-focussed pharmaceutical company Futura Medical announced on Tuesday that its topical gel formulation for the treatment of erectile dysfunction (ED), MED3000, is now available in the UK under the 'Eroxon' brand.

Read more
18 Apr 2023 12:32

Futura launches Eroxon erectile dysfunction gel in UK stores

(Alliance News) - Futura Medical PLC announced on Tuesday that its erectile dysfunction treatment gel Eroxon is now available for purchase in the UK.

Read more
5 Apr 2023 12:21

Futura Medical annual loss widens as eyes MED3000 progress

(Alliance News) - Futura Medical PLC said on Wednesday its annual loss widened as it focused on the commercialisation of its new MED3000 product.

Read more
29 Mar 2023 15:48

UK earnings, trading statements calendar - next 7 days

Thursday 30 March 
AO World PLCTrading Statement
Aquis Exchange PLCFull Year Results
Arbuthnot Banking Group PLCFull Year Results
Ascential PLCFull Year Results
BBGI Global Infrastructure SAFull Year Results
Chesnara PLCFull Year Results
Ebiquity PLCFull Year Results
Gattaca PLCHalf Year Results
Gresham House PLCFull Year Results
IGas Energy PLCFull Year Results
Impellam Group PLCFull Year Results
International Public Partnerships LtdFull Year Results
Ithaca Energy PLCFull Year Results
Microlise Group PLCFull Year Results
Moonpig Group PLCTrading Statement
PetroTal CorpFull Year Results
Renalytix PLCHalf Year Results
Revolution Beauty Group PLCFull Year Results
Robinson PLCFull Year Results
Secure Trust Bank PLCFull Year Results
Supermarket Income REIT PLCHalf Year Results
XLMedia PLCFull Year Results
Friday 31 March 
Amaroq Minerals LtdFull Year Results
Bank of Cyprus Holdings PLCFull Year Results
Computacenter PLCFull Year Results
Cooks Coffee Co LtdFull Year Results
CT Private Equity Trust PLCFull Year Results
Dignity PLCFull Year Results
ECO Animal Health Group PLCTrading Statement
HealthBeacon PLCFull Year Results
Impax Environmental Markets PLCFull Year Results
James Halstead PLCHalf Year Results
Jaywing PLCTrading Statement
JPMorgan American Investment Trust PLCFull Year Results
Numis Corp PLCTrading Statement
Mothercare PLCTrading Statement
Quarto Group IncFull Year Results
UK Oil & Gas PLCFull Year Results
Vanquis Banking Group PLCFull Year Results
Monday 3 April 
Downing Renewables & Infrastructure Trust PLCFull Year Results
Elixirr International PLCFull Year Results
Fidelity Japan Trust PLCFull Year Results
Gaming Realms PLCFull Year Results
HydrogenOne Capital Growth PLCFull Year Results
N4 Pharma PLCFull Year Results
Renew Holdings PLCTrading Statement
Tracsis PLCHalf Year Results
Tuesday 4 April 
accesso Technology Group PLCFull Year Results
Anexo Group PLCTrading Statement
Epwin Group PLCFull Year Results
Merchants Trust PLCFull Year Results
Renewi PLCTrading Statement
Saga PLCFull Year Results
Wednesday 5 April 
EnQuest PLCFull Year Results
Futura Medical PLCFull Year Results
Hilton Food Group PLCFull Year Results
Lookers PLCFull Year Results
Lords Group Trading PLCFull Year Results
RS Group PLCTrading Statement
Topps Tiles PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
29 Mar 2023 09:52

IN BRIEF: Futura responds to US FDA on erectile dysfunction treatment

Futura Medical PLC - Surrey, England-based sexual health-focused pharmaceutical company - Says it has submitted a full response to questions from the US Food & Drug Administration and confirmatory data regarding its MED3000 erectile dysfunction treatment. This is for the FDA to continue its review of the product. Notes that it expects the grant of the De Novo request in the second quarter of 2023. A De Novo classification by the FDA provides an alternate pathway to marketing approval for novel medical devices.

Read more
14 Mar 2023 14:33

Futura Medical confirms Europe launch of MED3000; awaits FDA approval

(Alliance News) - Futura Medical PLC on Tuesday said its MED3000 product is now available online in Europe under the brand name Erexon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account